<DOC>
	<DOCNO>NCT01654653</DOCNO>
	<brief_summary>The choice fluid therapy controversial cardiac surgery . Numerous study show colloid well compare crystalloids . Several previous study demonstrate Hypertonic Sodium Lactate ( HSL ) administration cardiac surgery show promise effect . This study aim compare hemodynamic effect fluid balance HSL 6 % Hydroxy Ethyl Starch ( HES ) .</brief_summary>
	<brief_title>Efficacy Safety Hypertonic Sodium Lactate Solution Compared With 6 % HES Solution CABG Patients</brief_title>
	<detailed_description>The primary objective prospective , randomize open-label study follow : - To evaluate clinical efficacy Hypertonic Sodium Lactate ( HSL ) comparison 6 % HES maintain hemodynamic stability intra CABG patient related hemodynamic status Body fluid balance . - To assess safety HSL intra CABG patient related define laboratory parameter clinical adverse event occur trial . Subjects meet enrolment criterion randomly assign HSL 6 % HES treatment group . Assessment comparability do unpaired student t-test Chi-Square test two-way ANOVA repeat measure follow post-hoc analysis significant difference find within two group . The hypothesis test HSL effective intra CABG surgery patient , require less volume well cardiac index , compare 6 % HES .</detailed_description>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<criteria>Male female , age 4580 year . CABG patient pump procedure . Ejection fraction &lt; 50 % Patients give write informed consent . Combined operation ( surgery ) Patients severe arrhythmia ( VT , AF rapid response , heart block ) severe hemodynamic imbalance . Severe bleed and/or reoperation . Hypernatremia &gt; 155 mmol/L Severe liver failure : SGOT SGPT twice normal . Severe renal failure : creatinine 2 mg % . Patients major disease cancer , etc .</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>Heart disease</keyword>
	<keyword>cardiac surgery</keyword>
	<keyword>CABG</keyword>
	<keyword>Totilac</keyword>
	<keyword>Voluven</keyword>
	<keyword>6 % HES</keyword>
</DOC>